These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3948125)

  • 1. Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study.
    van Nagell JR; Hanson MB; Donaldson ES; Gallion HH
    Cancer; 1986 Apr; 57(8):1451-4. PubMed ID: 3948125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
    Hempling RE; Piver MS; Baker TR
    Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
    Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
    Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
    Piver MS; Lele SB; Marchetti DL; Emrich LJ
    J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of chemotherapeutical protocols in the treatment of uterine sarcomas (Vincristine, actinomycin D, Cyclophosphamide VAC versus ifosfamide).
    Simşek T; Uner M; Trak B; Erman O; Zorlu GC
    Eur J Gynaecol Oncol; 1998; 19(4):405-7. PubMed ID: 9744738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for stage I uterine sarcoma.
    Rose PG; Boutselis JG; Sachs L
    Am J Obstet Gynecol; 1987 Mar; 156(3):660-2. PubMed ID: 3826216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy following surgery in the management of uterine sarcomas.
    Szánthó A; Bálega J; Szabó I; Demeter A; Sipos N; Csapó Z; Papp Z
    Eur J Gynaecol Oncol; 2003; 24(5):421-4. PubMed ID: 14584661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide.
    Hannigan EV; Freedman RS; Elder KW; Rutledge FN
    Gynecol Oncol; 1983 Apr; 15(2):224-9. PubMed ID: 6687580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
    Chang TC; Lai CH; Tseng CJ; Hsueh S; Huang KG; Chou HH
    Cancer; 1998 Aug; 83(4):712-8. PubMed ID: 9708935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
    Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
    Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of rhabdomyosarcoma of the uterus associated with uterine inversion.
    Case AS; Kirby TO; Conner MG; Huh WK
    Gynecol Oncol; 2005 Mar; 96(3):850-3. PubMed ID: 15721436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.
    Palumbo R; Palmeri S; Gatti C; Villani G; Cesca A; Toma S
    Oncol Rep; 1998; 5(1):69-72. PubMed ID: 9458296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in early uterine sarcoma.
    Hannigan EV; Freedman RS; Rutledge FN
    Gynecol Oncol; 1983 Feb; 15(1):56-64. PubMed ID: 6401640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.
    Edmonson JH; Fleming TR; Ivins JC; Burgert EO; Soule EH; O'Connell MJ; Sim FH; Ahmann DL
    J Clin Oncol; 1984 Dec; 2(12):1390-6. PubMed ID: 6512582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.
    Gershenson DM; Copeland LJ; Kavanagh JJ; Cangir A; Del Junco G; Saul PB; Stringer CA; Freedman RS; Edwards CL; Wharton JT
    Cancer; 1985 Dec; 56(12):2756-61. PubMed ID: 2996746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors.
    Peters WA; Rivkin SE; Smith MR; Tesh DE
    Gynecol Oncol; 1989 Sep; 34(3):323-7. PubMed ID: 2767523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.